Genomic Grade Index predicts postoperative clinical outcome of GIST

BACKGROUND: Prognosis of localised gastrointestinal stromal tumour (GIST) is heterogeneous, notably for patients with AFIP intermediate or high risk of relapse, who are candidates to adjuvant imatinib. We hypothesised that gene expression profiles might improve the prognostication and help to refine...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertucci, F, Finetti, P, Ostrowski, J, Kim, W K, Kim, H, Pantaleo, M A, Astolfi, A, Polkowski, M, Birnbaum, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494448/
https://www.ncbi.nlm.nih.gov/pubmed/22929880
http://dx.doi.org/10.1038/bjc.2012.390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494448/
https://www.ncbi.nlm.nih.gov/pubmed/22929880
http://dx.doi.org/10.1038/bjc.2012.390

Ejemplares similares